Showing results (1351-1360 of 1,468) with videos related to
Sort By:
Pageof 147
Bioinformatics (Oxford, England)|February 9, 2017
PatternMarkers & GWCoGAPS for novel data-driven biomarkers via whole transcriptome NMFGenevieve L Stein-O'Brien, Jacob L Carey, Wai Shing Lee, et al.Journal of Cellular Physiology|August 1, 2014
Runx1 Activities in Superficial Zone Chondrocytes, Osteoarthritic Chondrocyte Clones and Response to Mechanical LoadingKimberly T LeBlanc, Marie E Walcott, Tripti Gaur, et al.Endocrinology|June 3, 2016
Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid CancerFrances E Carr, Phillip W L Tai, Michael S Barnum, et al.Methods in Molecular Biology (Clifton, N.J.)|August 10, 2010
Subnuclear localization and intranuclear trafficking of transcription factorsSayyed K Zaidi, Ricardo F Medina, Shirwin M Pockwinse, et al.Methods in Molecular Biology (Clifton, N.J.)|May 9, 2008
In situ nuclear organization of regulatory machineryShirwin M Pockwinse, Sayyed K Zaidi, Ricardo F Medina, et al.Molecules (Basel, Switzerland)|January 28, 2026
Electrochemical Synthesis of 3-Selenyl-Chromones via Domino C(sp<sup>2</sup>)-H Bond Selenylation/Annulation of EnaminonesJoão M Brito, Isabella M E Oliveira, Cassio A O Moraes, et al.Journal of Cellular Biochemistry|November 19, 2003
Differential gene expression analysis using paraffin-embedded tissues after laser microdissectionJoung-Ok Kim, Hyun-Nam Kim, Mi-Hye Hwang, et al.Journal of Cellular Physiology|September 10, 2009
Impaired cell cycle regulation of the osteoblast-related heterodimeric transcription factor Runx2-Cbfbeta in osteosarcoma cellsInga A San Martin, Nelson Varela, Marcia Gaete, et al.Cancer Research|June 10, 2010
Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expressionKyle C Kurek, Sara Del Mare, Zaidoun Salah, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617FBrady L Stein, Stephen T Oh, Dmitriy Berenzon, et al.Pageof 147